Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-06-23 | 2017-07-11 | 13861 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-07-27 | 2017-09-13 | 17414 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2017-09-18 | 2017-11-02 | 22359 |
| TOBRADEX | 0.1% 0.3% | OINTMENT | Resolved | 2018-12-19 | 2019-02-02 | 70039 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2017-09-05 | 2017-09-14 | 20969 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2017-11-30 | 2018-01-18 | 31276 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-12-11 | 44015 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2018-03-26 | 2018-06-22 | 44018 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-09-08 | 2020-10-08 | 123880 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2020-12-10 | 2021-01-20 | 130021 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-05-19 | 2023-09-27 | 192835 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-09-27 | 2024-02-03 | 205330 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2018-09-28 | 2018-10-17 | 62545 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Resolved | 2023-04-28 | 2023-10-04 | 191074 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-01 | 2018-06-19 | 51063 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-06-22 | 2018-07-27 | 52770 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2018-08-15 | 2018-10-18 | 58228 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2020-04-20 | 2020-09-08 | 112537 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |